ACI Formulations Limited Stock price

Equities

ACIFORMULA

BD0480ACIFL4

Agricultural Chemicals

End-of-day quote Dhaka S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
130.1 BDT +0.39% Intraday chart for ACI Formulations Limited -4.83% -16.06%
Sales 2022 4.25B 38.63M Sales 2023 4.96B 45.11M Capitalization 7.38B 67.13M
Net income 2022 243M 2.21M Net income 2023 235M 2.14M EV / Sales 2022 2.34 x
Net Debt 2022 2.47B 22.51M Net Debt 2023 2.6B 23.63M EV / Sales 2023 2.01 x
P/E ratio 2022
30.8 x
P/E ratio 2023
31.4 x
Employees 985
Yield 2022
1.58%
Yield 2023
1.6%
Free-Float 27.71%
More Fundamentals * Assessed data
Dynamic Chart
ACI Formulations Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
ACI Formulations Limited Recommends Cash Dividend for the Year Ended June 30, 2023 CI
ACI Formulations Limited Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
ACI Formulations Limited Announces Executive Changes CI
ACI Formulations Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023 CI
ACI Formulations Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022 CI
ACI Formulations Limited Reports Earnings Results for the First Quarter Ended September 30, 2022 CI
ACI Formulations Limited Recommends Cash Dividend for the Year Ended June 30, 2022 CI
ACI Formulations Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022 CI
ACI Formulations Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021 CI
ACI Formulations Limited Recommends Cash Dividend for the Year Ended on June 30, 2021 CI
ACI Formulations Limited Reports Earnings Results for the First Quarter Ended September 30, 2020 CI
ACI Formulations Limited Recommends Cash Dividend for the Year Ended on June 30, 2020 CI
ACI Formulations Limited Recommends Cash Dividend for the Year Ended on June 30, 2019 CI
ACI Formulations Limited Reports Earnings Results for the Third Quarter Ended March 31, 2019 CI
More news
1 day+0.39%
1 week-4.83%
Current month-7.86%
1 month-7.67%
3 months-16.06%
6 months-16.06%
Current year-16.06%
More quotes
1 week
128.00
Extreme 128
137.50
1 month
127.50
Extreme 127.5
141.20
Current year
127.50
Extreme 127.5
155.00
1 year
127.50
Extreme 127.5
172.00
3 years
100.00
Extreme 100
225.90
5 years
76.29
Extreme 76.2857
225.90
10 years
74.76
Extreme 74.7619
244.48
More quotes
Managers TitleAgeSince
Chief Executive Officer - 03-02-08
Director of Finance/CFO - -
Chairman 87 95-10-29
Members of the board TitleAgeSince
Chairman 87 95-10-29
Director/Board Member 69 95-10-31
Director/Board Member 53 03-02-08
More insiders
Date Price Change Volume
24-03-28 130.1 +0.39% 6,773
24-03-27 129.6 -1.07% 5,475
24-03-25 131 -2.53% 5,548
24-03-24 134.4 -1.68% 6,647
24-03-21 136.7 +5.32% 12,091

End-of-day quote Dhaka S.E., March 27, 2024

More quotes
ACI Formulations Limited is a Bangladesh-based company, which is engaged in the manufacturing and marketing of a number of agrochemical and consumer products. The Company operates through four segments: Crop Care and Public Health (CC & PH), Mosquito coil (M.Coil), Aerosol and Paint. The CC & PH segment manufactures and sells crop care and public health products. The M.Coil segment manufactures and sells mosquito coil products. The Aerosol segment manufactures and sells aerosol and air freshener products. The Paint segment manufactures and sells paint products. Its subsidiaries include Neem Laboratories (Pvt.) Ltd and ACI AgroChem Limited. Neem Laboratories (Pvt.) Ltd is engaged in manufacturing and marketing of herbal products to make available the benefits of Neem and other herbs to the consumers. ACI AgroChem Limited manufacture and market various kinds of agricultural input like chemical, including other allied and general chemical.
More about the company
  1. Stock
  2. Equities
  3. Stock ACI Formulations Limited - Dhaka S.E.